Deferred Tax Assets, Valuation Allowance in USD of BioSig Technologies, Inc. from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioSig Technologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2013 to Q4 2024.
  • BioSig Technologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $47M, a 15.2% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BioSig Technologies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $47M -$8.44M -15.2% 31 Dec 2024 10-K 15 Apr 2025
Q4 2023 $55.4M +$7.74M +16.2% 31 Dec 2023 10-K 15 Apr 2025
Q4 2022 $47.7M +$16.5M +53% 31 Dec 2022 10-K 16 Apr 2024
Q4 2021 $31.2M +$6.47M +26.2% 31 Dec 2021 10-K 31 Mar 2023
Q4 2020 $24.7M +$9.2M +59.4% 31 Dec 2020 10-K 31 Mar 2022
Q4 2019 $15.5M +$8.3M +115% 31 Dec 2019 10-K 15 Mar 2021
Q4 2018 $7.2M -$1M -12.2% 31 Dec 2018 10-K 13 Mar 2020
Q4 2017 $8.2M +$2.7M +49.1% 31 Dec 2017 10-K 15 Mar 2019
Q4 2016 $5.5M +$1.8M +48.6% 31 Dec 2016 10-K 27 Feb 2018
Q4 2015 $3.7M +$1.4M +60.9% 31 Dec 2015 10-K 11 Apr 2017
Q4 2014 $2.3M +$900K +64.3% 31 Dec 2014 10-K 14 Mar 2016
Q4 2013 $1.4M 31 Dec 2013 10-K 20 Feb 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.